DPP HIV 1/2 Assay regulatory update

Chembio submitted a CLIA waiver application to FDA for its DPP HIV 1/2 Assay as an aid in diagnosing HIV/AIDS infection in patients >=2 years. The company hopes to launch the product in 2Q14. FDA appr...